Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M296Revenue (TTM) $M7.8Net Margin (%)-686.1Altman Z-Score-4.5
Enterprise Value $M318EPS (TTM) $-0.7Operating Margin %-969.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.5Pre-tax Margin (%)-928.5Higher ROA y-yN
Price/Book26.010-y EBITDA Growth Rate %32.4Quick Ratio2.4Cash flow > EarningsY
Price/Sales32.55-y EBITDA Growth Rate %28.1Current Ratio2.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-67.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-288.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M95.0ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with BTX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BTX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BROADWOOD PARTNERS LPDirector, 10% Owner 2016-06-21Buy2,732,636$2.3930.54view
BROADWOOD PARTNERS LPDirector, 10% Owner 2016-01-20Buy300,000$2.3532.77view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2016-01-20Sell300,000$2.3532.77view
FARRELL STEPHEN CDirector 2015-11-06Buy50,000$3.83-18.54view
Russell Angus C.Director 2015-11-06Buy50,000$3.83-18.54view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2015-11-06Sell100,000$3.83-18.54view
ANDREWS DEBORAH JDirector 2015-08-26Buy2,000$2.8210.64view
Cartt Stephen LaHueDirector 2015-08-18Buy75,000$2.811.43view
Russell Angus C.Director 2014-12-12Sell0$011.43view
Cartt Stephen LaHueDirector 2014-11-04Sell0$011.43view

Quarterly/Annual Reports about BTX:

News about BTX:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BTX, CWST, BKSC, STAG Jun 27 2011 
Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 

More From Other Websites
BioTime, Inc. to Report Second Quarter Results on August 9, 2016 Jul 27 2016
BioTime, Inc. to Report Second Quarter Results on August 9, 2016 Jul 27 2016
ETF’s with exposure to BioTime, Inc. : July 21, 2016 Jul 21 2016
Corporate Document-Investor Presentation for BioTime, Inc. Jul 20 2016
ETF’s with exposure to BioTime, Inc. : July 7, 2016 Jul 07 2016
BIOTIME INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 05 2016
BioTime, Inc. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option Jul 05 2016
BioTime, Inc. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option Jul 05 2016
BioTime Presents Online Resource for Applying Artificial Intelligence to Stem Cell Biology at Mensa... Jun 29 2016
BioTime Presents Online Resource for Applying Artificial Intelligence to Stem Cell Biology at Mensa... Jun 29 2016
BioTime, Inc. Announces Closing of Public Offering of Common Stock Jun 21 2016
BioTime, Inc. Announces Closing of Public Offering of Common Stock Jun 21 2016
BIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Jun 17 2016
A Look at Five Stocks that Are Trending on Thursday Jun 16 2016
BioTime, Inc. Announces Pricing of Public Offering of Common Stock Jun 16 2016
BioTime, Inc. Announces Pricing of Public Offering of Common Stock Jun 16 2016
BIOTIME INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 15 2016
BioTime, Inc. Announces Proposed Public Offering of Common Stock Jun 15 2016
BioTime, Inc. Announces Proposed Public Offering of Common Stock Jun 15 2016
BioTime’s Subsidiary Cell Cure Neurosciences Receives DSMB Approval to Start Second Patient Cohort... Jun 13 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)